Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

AXON Axon Enterprise Earnings and EPS analysis

EPS in 2025 (TTM): $4.35

Last Report Period Date: Mar 31, 2025

As of June 2025, AXON's current EPS stands at $4.35, according to the latest financial reports. For the year 2024, the company recorded an earnings per share (EPS) of $4.98, which marks an increase compared to its EPS of $2.37 in 2023. AXON reported an EPS of $1.14 for the quarterly report ending on Mar 31, 2025.

AXON earnings history

Historical annual and quarterly earnings per share (EPS) data for Axon Enterprise
EPS (TTM)
$4.35
EPS Growth YoY (Quarterly)
-35.6%
EPS (Quarterly)
$1.14
EPS Growth (Quarterly)
-36%

For 2024, Axon Enterprise's EPS was $4.98, an increase of 110.1% from $2.37 in 2023. For the fiscal quarter that ended on Mar 31, 2025, the per-share earnings was $1.14, showing a 35.6% decrease from the same quarter last year. For the twelve months ending March 2025, the EPS is $4.35. For the year 2023, the yearly earnings per share was $2.37, marking an increase of 14.5% from 2022.

AXON EPS growth

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-35.6%
EPS growth YoY
110.1%
EPS growth 3Y avg
N/A
EPS growth 5Y avg
246.3%

Axon Enterprise has registered a decrease in EPS of 35.6% during the last 12 months (YoY, quarterly). Axon Enterprise had an average annual EPS growth rate of 246.3% during the last 5 years. Across the last decade, AXON had an average annual EPS growth of 29.3%.

AXON Earnings Waterfall

Breakdown of revenue, profit and net income for Axon Enterprise

AXON Earnings vs Peers

What are the earnings of AXON compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
EXEL Exelixis Inc 18.58 176.9% 35.1% 11.2%
AXON Axon Enterprise Inc 181.09 110.1% N/A 246.3%
SGMO Sangamo Therapeutics Inc N/A 66.9% N/A N/A
XBIT XBiotech Inc N/A -55.6% N/A N/A
QURE uniQure NV N/A 24% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.